These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 38751753)

  • 1. Construction of an immune-related gene prognostic model with experimental validation and analysis of immune cell infiltration in lung adenocarcinoma.
    Yang J; Tang C; Li C; Li X; Yang W
    Oncol Lett; 2024 Jul; 28(1):297. PubMed ID: 38751753
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Construction of a Prognostic Immune-Related LncRNA Risk Model for Lung Adenocarcinoma.
    Li Y; Shen R; Wang A; Zhao J; Zhou J; Zhang W; Zhang R; Zhu J; Liu Z; Huang JA
    Front Cell Dev Biol; 2021; 9():648806. PubMed ID: 33869203
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prognosis and immunotherapy significances of a cancer-associated fibroblasts-related gene signature in lung adenocarcinoma.
    Luo Y; Zhang S; Xie H; Su Q; He S; Lei Z
    Cell Mol Biol (Noisy-le-grand); 2023 Dec; 69(14):51-61. PubMed ID: 38279482
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comprehensive analysis to identify a novel diagnostic marker of lung adenocarcinoma and its immune infiltration landscape.
    Zhu A; Pei D; Zong Y; Fan Y; Wei S; Xing Z; Song S; Wang X; Gao X
    Front Oncol; 2023; 13():1199608. PubMed ID: 37409245
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Development of the prognostic value in lung adenocarcinoma based on anoikis-related genes and initial experimental validation.
    Guo W; Zhao G; Liu S; Deng T; Zhang G; Zhang B
    J Gene Med; 2023 Sep; 25(9):e3534. PubMed ID: 37259225
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Analysis of expression differences of immune genes in non-small cell lung cancer based on TCGA and ImmPort data sets and the application of a prognostic model.
    Sun L; Zhang Z; Yao Y; Li WY; Gu J
    Ann Transl Med; 2020 Apr; 8(8):550. PubMed ID: 32411773
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognostic value of lncRNAs related to fatty acid metabolism in lung adenocarcinoma and their correlation with tumor microenvironment based on bioinformatics analysis.
    Pan YQ; Xiao Y; Long T; Liu C; Gao WH; Sun YY; Liu C; Shi YJ; Li S; Shao AZ
    Front Oncol; 2022; 12():1022097. PubMed ID: 36300102
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Screening and evaluation of the role of immune genes of brain metastasis in lung adenocarcinoma progression based on the TCGA and GEO databases.
    Chen C; Guo Q; Tang Y; Qu W; Zuo J; Ke X; Song Y
    J Thorac Dis; 2021 Aug; 13(8):5016-5034. PubMed ID: 34527340
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A new prognostic model for
    Li Q; Liu XL; Jiang N; Li QY; Song YX; Ke XX; Han H; Luo Q; Guo Q; Luo XY; Chen C
    J Thorac Dis; 2023 Apr; 15(4):1919-1934. PubMed ID: 37197482
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Selective poly adenylation predicts the efficacy of immunotherapy in patients with lung adenocarcinoma by multiple omics research.
    Wu L; Zhong Y; Yu X; Wu D; Xu P; Lv L; Ruan X; Liu Q; Feng Y; Liu J; Li X
    Anticancer Drugs; 2022 Oct; 33(9):943-959. PubMed ID: 35946526
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The role of radiotherapy-related autophagy genes in the prognosis and immune infiltration in lung adenocarcinoma.
    Gao J; Lu F; Yan J; Wang R; Xia Y; Wang L; Li L; Chang L; Li W
    Front Immunol; 2022; 13():992626. PubMed ID: 36311724
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comprehensive analysis identifies DNA damage repair-related gene HCLS1 associated with good prognosis in lung adenocarcinoma.
    Liu T; Hu A; Chen H; Li Y; Wang Y; Guo Y; Liu T; Zhou J; Li D; Chen Q
    Transl Cancer Res; 2023 Oct; 12(10):2613-2628. PubMed ID: 37969376
    [TBL] [Abstract][Full Text] [Related]  

  • 13. AUNIP Expression Is Correlated With Immune Infiltration and Is a Candidate Diagnostic and Prognostic Biomarker for Hepatocellular Carcinoma and Lung Adenocarcinoma.
    Ma C; Kang W; Yu L; Yang Z; Ding T
    Front Oncol; 2020; 10():590006. PubMed ID: 33363020
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hypoxia-related gene signature for predicting LUAD patients' prognosis and immune microenvironment.
    Chen J; Fu Y; Hu J; He J
    Cytokine; 2022 Apr; 152():155820. PubMed ID: 35176657
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Construction of Lymph Node Metastasis-Related Prognostic Model and Analysis of Immune Infiltration Mode in Lung Adenocarcinoma.
    Li W; Ou D; Zhang J; Ye M
    Comput Math Methods Med; 2022; 2022():3887857. PubMed ID: 35836921
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic value of CCR2 as an immune indicator in lung adenocarcinoma: A study based on tumor-infiltrating immune cell analysis.
    Wan Y; Wang X; Liu T; Fan T; Zhang Z; Wang B; Zhang B; Tian Z; Mao T; Gong Z; Zhang L
    Cancer Med; 2021 Jun; 10(12):4150-4163. PubMed ID: 33949150
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Integrated analysis and validation reveal ACAP1 as a novel prognostic biomarker associated with tumor immunity in lung adenocarcinoma.
    Wang N; Zhu L; Xu X; Yu C; Huang X
    Comput Struct Biotechnol J; 2022; 20():4390-4401. PubMed ID: 36051873
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Glycolysis Define Two Prognostic Subgroups of Lung Adenocarcinoma With Different Mutation Characteristics and Immune Infiltration Signatures.
    Huo C; Zhang MY; Li R; Liu TT; Li JP; Qu YQ
    Front Cell Dev Biol; 2021; 9():645482. PubMed ID: 34368114
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A novel anoikis-related gene signature to predict the prognosis, immune infiltration, and therapeutic outcome of lung adenocarcinoma.
    Wang Y; Xie C; Su Y
    J Thorac Dis; 2023 Mar; 15(3):1335-1352. PubMed ID: 37065587
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Development and validation of a DNA damage repair-related gene-based prediction model for the prognosis of lung adenocarcinoma.
    Qin C; Fan X; Sai X; Yin B; Zhou S; Addeo A; Bian T; Yu H
    J Thorac Dis; 2023 Dec; 15(12):6928-6945. PubMed ID: 38249902
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.